Potomac Capital Management’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16M Sell
155,071
-18,731
-11% -$1.1M 10.89% 2
2026
Q1
$6.64M Buy
173,802
+12,402
+8% +$392K 5.77% 2
2025
Q4
$3.52M Buy
+161,400
New +$3.35M 2.83% 7

Other funds holding ATEX

Potomac Capital Management's ATEX Position: Q2 2026 in Review

Potomac Capital Management reduced its Anterix (ATEX) stake by 11% in Q2 2026, selling an estimated $1.1M and leaving 155,071 shares worth $16M. The position accounts for 10.89% of the portfolio, ranked #2.

Potomac Capital Management first reported a position in ATEX in Q4 2025 and has held it in 3 quarters since. 172 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.

  • Potomac Capital Management held 155,071 shares of Anterix worth $16M as of Q2 2026.
  • Potomac Capital Management sold 18,731 Anterix shares in Q2 2026, an estimated $1.1M.
  • Anterix made up 10.89% of Potomac Capital Management's portfolio in Q2 2026, its #2 holding.
  • Potomac Capital Management first reported a position in Anterix in Q4 2025 and has held it in 3 quarters since.
  • 172 funds tracked by Wall St. Rank held Anterix as of Q2 2026.

Based on Potomac Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.